Olga Yurievna Povnitsa

Dr. Olga Yurievna Povnitsa

Danylo Zabolotny Institute of Microbiology and Virology, Kyiv, Kyyiv, Misto, Ukraine
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Advances in Natural Sciences: Nanoscience and Nanotechnology
Verified
Journal Article
Open access
VLV Lysenko
V Lysenko
VLV Lozovski
V Lozovski
MLM Lokshyn
M Lokshyn
YGYu V Gomeniuk
Yu V Gomeniuk
ADA Dorovskih
A Dorovskih
YBYu Bolbukh
Yu Bolbukh

22 August 2019 in Medicina
Verified
Journal Article
Open access
PDF file
L(Liubov Oleksiivna Artiukh (Biliavska)
Liubov Oleksiivna Artiukh (Biliavska)
YPYulia Pankivska
Yulia Pankivska
OPOlga Yurievna Povnitsa
Olga Yurievna Povnitsa
SZSvitlana D Zahorodnia
Svitlana D Zahorodnia
Background and objectives: The use of antagonistic probiotic microorganisms and their byproducts represents a promising approach for the treatment of viral diseases. In the current work, the effect of exopolysaccharides (EPSs) produced by lactic acid bacteria from different genera on the structural and functional characteristics of cells and the development of adenoviral infection in vitro was studied. Materials and Methods: Cytotoxicity of six EPSs of lactic acid bacteria of the genera Lactobacillus, Leuconostoc and Pediococcus was determined by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay. The influence of the EPSs on the infectivity of human adenovirus type 5 (HAdV-5) and on the cell cycle under a condition of adenovirus infection was studied using plaque reduction assay and flow cytometric analysis, respectively. Results: It was shown that exopolysaccharides were non-toxic to Madin-Darby bovine kidney cells (MDBK) as they reduced their viability by 3–17%. A change in the distribution of the cell cycle phases in the non-infected cell population treated with EPSs was observed. The analysis demonstrated an increase in the number of cells in the S phase by 47% when using EPSs 15a and a decrease in the number of cells in the G1 phase by 20–27% when treated with the EPSs 15a, 33a, and 19s. The use of EPSs did not led to the normalization of the life cycle of HAdV-5 infected cells to the level of non-infected cells. The EPSs showed low virucidal activity and reduced the HAdV-5 infectivity to 85%. Among the studied exopolysaccharides, anti-adenovirus activity was found for EPS 26a that is produced by Lactobacillus spp. strain. The treatment of cells with the EPS following virus adsorption completely (100%) suppressed the formation and release of HAdV-5 infectious. Conclusions: EPS 26a possessed distinct anti-HAdV-5 activity and the obtained data demonstrate the potential of using exopolysaccharides as anti-adenoviral agents.

31 March 2001 in Nucleosides, Nucleotides & Nucleic Acids
Verified
Journal Article
Closed access
IAI. Alexeeva
I. Alexeeva
NDN. Dyachenko
N. Dyachenko
LNL. Nosach
L. Nosach
VZV. Zhovnovataya
V. Zhovnovataya
SRS. Rybalko
S. Rybalko
OPOlga Yurievna Povnitsa
Olga Yurievna Povnitsa
6-azacytidine demonstrates activity against adenoviruses types 1, 2, 5. It inhibit synthesis of viral DNA and proteins. 6-AC shows antiherpetic and antiinfluenza action during experimental infection in mice. 6-AC is prospective for drug development as an antiviral substance with a wide spectrum of activity.

16 January 2020 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
Maryna StasevychMaryna Stasevych
Maryna Stasevych
VZV. I. Zvarich
V. I. Zvarich
VNV. P. Novikov
V. P. Novikov
SZSvitlana D Zahorodnia
Svitlana D Zahorodnia
OPOlga Yurievna Povnitsa
Olga Yurievna Povnitsa
VPV. V. Poroikov
V. V. Poroikov

1 February 2007 in Journal of Chemotherapy
Verified
Journal Article
Closed access
VZVladimir Zarubaev
Vladimir Zarubaev
ASA.V. Slita
A.V. Slita
VSV.P. Sukhinin
V.P. Sukhinin
LNL.N. Nosach
L.N. Nosach
NDN.S. Dyachenko
N.S. Dyachenko
LPL.I. Palchikovskaya
L.I. Palchikovskaya
Adenoviral infection is a serious human pathology leading to respiratory, gastrointestinal and ocular disorders and epidemic outbreaks, especially in children's groups. Here we present the results from an investigation of anti- adenoviral effect of 6-azacytidine (6-AC) both in vitro and in vivo. The selectivity index of 6-AC for adenovirus type 5 in HEp-2 cells was 374, the 50% effective concentration was 0.5 mg/ml. For in vivo investigations we developed a model of disseminated adenoviral infection in newborn Syrian hamsters. The infectious virus was recovered from the liver, kidney, lungs and heart. Application of 6-AC led to a reduced period of the virus presence (7 days in the liver and 4 days in the kidney and heart) and lowered virus titers on day 3 post-inoculation (p.i.) (liver - 2.7 and 4.1, heart - 0 and 3.2, kidney - 0 and 2.4 log(10 )CPD(50)/mg tissue weight, in the presence and absence of 6-AC, respectively). Application of 6-AC to newborn Syrian hamsters led to partial destruction of their splenocytes. The results obtained suggest that 6-AC or 6-ACbased drugs with lower toxicity or applied topically may be suitable for therapy and prevention of adenoviral infection in humans.

8 October 2022 in Journal of Toxicology
Verified
Journal Article
Open access
PDF file
L(Liubov Oleksiivna Artiukh (Biliavska)
Liubov Oleksiivna Artiukh (Biliavska)
OPOlga Yurievna Povnitsa
Olga Yurievna Povnitsa
SZSvitlana D Zahorodnia
Svitlana D Zahorodnia
CPCalin V. Pop
Calin V. Pop
NRNodari Rizun
Nodari Rizun
Unique properties of silver nanoparticles (NPs) ensure their wide applications, in biomedicine; for this reason, it is very important carefully to study the toxicity of such NPs. The influence of silver nanoparticles coated with natural resin (Ag NPs) on the morphological and functional features of healthy BHK-21 and cancerous Hep-2 cells were studied using fluorescence microscopy, MTT, and neutral red assays. Ag NPs induced morphological changes in both cell cultures. The modifications were dose-dependent and more pronounced with an increase in NPs concentration. The IC50 value of Ag NPs for Hep-2 cells was found to be 2.190.22µg/mL, whereas for BHK-21 cells it was significantly (5x) higher at 10.922.48µg/mL. The use of NPs at a concentration close to IC50 leads to significant increase (up to 40) in the number of necrotic cells in cancerous cell population and a decrease in the number of mitotic cells (up to 1.3). In noncancerous cells the cellular parameters were similar to the control cells. These data suggest that the silver nanoparticles coated with natural resin can be potentially used in cancer therapy.